Recall report: More Chantix lots pulled from shelves as nitrosamine woes continue

Another four lots of Pfizer’s popular anti-smoking drug have been recalled due to high levels of nitrosamine, the FDA announced.

Pifzer halted distribution of Chantix and recalled four lots of the drug in June, after finding elevated levels of cancer-causing nitrosamines. Despite the recall, an official at Pfizer Korea said the company believes the benefits of the non-smoking drug outweigh any potential risk of exposure to nitrosamines, and that those who have been taking it should continue to do so.